Instalab

Hazelnut (Cor a 8) IgE Test Blood

See whether your hazelnut sensitivity is the type linked to severe, whole-body reactions.

Should you take a Hazelnut (Cor a 8) IgE test?

This test is most useful if any of these apply to you.

Reacting to Hazelnuts Beyond a Mouth Itch
If hazelnut has caused hives, swelling, or whole-body symptoms, this test can show whether a more severe allergy pattern is driving it.
Allergic to Multiple Plant Foods
If you also react to peach, peanut, or other nuts and seeds, this test helps map whether lipid transfer protein allergy is the common thread.
Roots in the Mediterranean
If you or your family come from Spain, Italy, or similar regions, lipid transfer protein allergy is more common, and this test offers targeted insight.
Parents of a Child With Suspected Nut Allergy
If your child has reacted to hazelnut, this component test paired with storage protein testing helps clarify the type of allergy and risk.

About Hazelnut (Cor a 8) IgE

If you have ever reacted to hazelnuts, or you live somewhere where hazelnuts cause more than just an itchy mouth, this test can help clarify what kind of allergy you are actually dealing with. It looks for a specific antibody your immune system makes against Cor a 8, one hazelnut protein in particular.

Cor a 8 belongs to a family of plant proteins linked to more severe, whole-body reactions in some people, especially in Mediterranean regions. Knowing whether you carry this antibody helps separate a mild oral itch from a pattern that can escalate to hives, swelling, or trouble breathing.

What This Test Actually Measures

This is a blood test for IgE (immunoglobulin E) antibodies directed at Cor a 8, a hazelnut lipid transfer protein. Lipid transfer proteins are small, sturdy plant proteins that survive cooking and digestion, which is part of why they can trigger reactions further down the body, not just in the mouth. A positive result means your immune system has built antibodies against this particular protein.

Cor a 8 is one of several hazelnut components doctors can test individually. The others most often measured are Cor a 1 (a protein closely related to birch pollen, usually tied to milder mouth symptoms) and the storage proteins Cor a 9 and Cor a 14 (linked to whole-body reactions in children). Each component tells a different story about what kind of hazelnut allergy you have.

Why a Positive Cor a 8 Matters

A positive Cor a 8 result points toward what allergists call lipid transfer protein allergy, a pattern that tends to involve more than just oral symptoms. In a study of children from a birch-endemic area, every child who had objective systemic reactions during a controlled hazelnut challenge had detectable Cor a 8 IgE, and sensitization to Cor a 8 remained an independent risk factor for those reactions.

In Italian children with suspected hazelnut allergy, higher Cor a 8 IgE was associated with greater odds of failing an oral food challenge, meaning a real reaction during a supervised feeding test. In Mediterranean populations such as Spain and Italy, Cor a 8 is one of the main drivers of hazelnut allergy, while in Northern and Western Europe, hazelnut reactions are more often birch-pollen-related and milder.

What a Negative Cor a 8 Does Not Tell You

A negative Cor a 8 does not rule out hazelnut allergy. Many people who react to hazelnuts, especially children, are negative for Cor a 8 but positive for storage proteins Cor a 9 or Cor a 14. A systematic review of lipid transfer protein assays found Cor a 8 sensitivity of only 11 to 43 percent for hazelnut allergy. A pediatric-focused review reported sensitivity around 5 percent (95% CI 0.6 to 16.9), with the curve measuring overall accuracy at roughly 58 percent, much weaker than Cor a 9 or Cor a 14.

Put simply, Cor a 8 is a high-specificity, low-sensitivity marker. A positive result usefully confirms a particular kind of hazelnut allergy. A negative result by itself cannot exclude allergy, because your reaction may be driven by a completely different hazelnut protein.

Resolving the Apparent Contradiction

It can feel confusing that a single test is both meaningful when positive and unable to exclude disease when negative. Cor a 8 is not a yes-or-no answer for hazelnut allergy. It is a phenotype marker, telling you which type of allergic pattern you are most likely dealing with. A positive Cor a 8 means lipid transfer protein allergy, often more systemic. A negative Cor a 8 simply means your hazelnut reactions, if any, are probably driven by something else, like storage proteins or birch-related proteins. Both findings carry information, but they answer different questions.

Severe Reaction Risk

Cor a 8 sensitization has been linked to a wider range of clinical reactions than birch-related hazelnut allergy, including hives, swelling, breathing problems, and anaphylaxis. In Mediterranean cohorts, Cor a 8 is a major driver of hazelnut-related systemic reactions, and in Dutch children, Cor a 8 sensitization was associated with objective symptoms during supervised hazelnut challenges.

What this means for you: if Cor a 8 is positive and you have ever had reactions beyond mouth itching after hazelnut or other tree nuts, you should be working with an allergist on a clear avoidance plan and carrying epinephrine if prescribed. The presence of Cor a 8 IgE puts you in a higher-risk category than someone with only Cor a 1 sensitization.

Cross-Reactivity With Other Foods

Lipid transfer proteins exist in many plant foods, and your Cor a 8 result rarely lives in isolation. Cor a 8 IgE often coexists with IgE to other lipid transfer proteins, including Ara h 9 from peanut and Pru p 3 from peach, reflecting a broader pattern allergists call lipid transfer protein syndrome. People with this profile may react to multiple nuts, seeds, fruits, and vegetables, not just hazelnut.

In a cohort of 285 patients evaluated for lipid transfer protein allergy, sensitization to peanut and hazelnut lipid transfer protein supported the diagnosis alongside the peach marker. If your Cor a 8 is positive, it is worth checking other lipid transfer protein components to map out which foods may be involved.

How This Compares With Standard Hazelnut Allergy Testing

Most standard allergy panels report whole hazelnut extract IgE, which lumps together antibodies to all hazelnut proteins. Whole extract testing is highly sensitive (around 96 percent) but poorly specific (about 11 percent), meaning it picks up many people who would never actually react. Component testing for Cor a 8, Cor a 9, and Cor a 14 separates the signal: which specific proteins your immune system targets, and what that means for your real-world risk.

If your standard hazelnut IgE comes back positive, component testing helps decide whether you are facing a mild pollen-related reaction or a potentially systemic one. If your standard hazelnut IgE is negative but you have had unexplained reactions, component testing including Cor a 8 can still surface a meaningful answer.

Why Tracking Your Levels Over Time Helps

A single Cor a 8 reading is a snapshot, not a verdict. Sensitization patterns can shift with age, and the clinical significance of a positive result is best understood in the context of your symptom history and other components. Get a baseline if you have a personal or family history of food reactions, and retest if your symptoms change, you add new reactions to other plant foods, or you start an intervention like immunotherapy.

For most people with stable disease, retesting every one to two years is reasonable. If you are undergoing oral immunotherapy or sublingual immunotherapy for hazelnut allergy, more frequent monitoring under your allergist's guidance lets you track whether your immune system is moving toward tolerance.

What to Do With an Unexpected Result

If Cor a 8 comes back positive and you have never had a reaction, do not start an avoidance plan based on the number alone. Sensitization is not the same as allergy. Work with an allergist who can integrate Cor a 8 with Cor a 9, Cor a 14, whole hazelnut IgE, a skin prick test, and your clinical history. In adults from birch-endemic areas, even combining extract and components cannot safely replace a supervised oral food challenge when the picture is unclear.

If Cor a 8 is positive and you have had systemic reactions, expand the workup. Add components for peanut (Ara h 9), peach (Pru p 3), and other lipid transfer proteins to map your full allergy profile. Discuss whether you should carry epinephrine, and consider seeing a specialist who can advise on hazelnut sublingual or oral immunotherapy, the only interventions shown to meaningfully change the underlying allergic biology.

Diagnostic Performance at a Glance

Who Was StudiedWhat Was ComparedWhat They Found
Patients with suspected hazelnut allergy across three studies (~934 people)Cor a 8 IgE blood test results against confirmed hazelnut allergyCaught roughly 11 to 43 out of 100 cases, but correctly cleared 59 to 94 out of 100 non-allergic patients
Children evaluated with hazelnut component testingCor a 8 versus Cor a 9 and Cor a 14 for diagnosing real hazelnut allergyCor a 8 was a much weaker single marker than the storage proteins, which performed substantially better
Dutch children from a birch-endemic area undergoing supervised hazelnut challengesCor a 8 status compared between those with objective systemic reactions and othersAll children with objective systemic reactions had detectable Cor a 8 IgE

Sources: Bellia et al. 2024 systematic review; Caffarelli et al. 2021 systematic review; Flinterman et al. 2008.

What Moves This Biomarker

Evidence-backed interventions that affect your Hazelnut (Cor a 8) IgE level

Decrease
Sublingual immunotherapy with standardized hazelnut extract
You can train your immune system to tolerate more hazelnut protein. In a randomized, double-blind, placebo-controlled trial of 23 hazelnut-allergic adults and older children, sublingual immunotherapy with a standardized hazelnut extract raised the tolerated hazelnut dose from 2.29 grams to 11.56 grams over 8 to 12 weeks, with increased IgG4 (a protective antibody) and IL-10 (an immune-calming signal). The maintenance dose included 24.34 micrograms of Cor a 8.
MedicationStrong Evidence
Decrease
Oral immunotherapy with hazelnut protein
You can substantially raise the amount of hazelnut your body can handle before reacting. In a single-center study of 88 children, hazelnut oral immunotherapy desensitized 52.2 percent of participants in intention-to-treat analysis and 76.7 percent per protocol over roughly 12 months, raising the challenge threshold from 187 milligrams to 1,490 milligrams of hazelnut protein. In a separate Italian cohort of 124 children, the regimen significantly reduced Cor a 14 IgE and skin prick test wheal size, though anaphylaxis occurred in 8.8 percent.
MedicationStrong Evidence
Decrease
Omalizumab combined with oral immunotherapy
You can reach higher tolerance thresholds for tree nuts, including hazelnut, by adding this anti-IgE biologic. In pooled tree-nut cohorts including hazelnut, about 55 percent of patients on omalizumab plus oral immunotherapy reached at least 1,000 milligrams of tolerated nut protein, versus 8.7 percent with placebo. Effects on Cor a 8 IgE specifically are not reported.
MedicationStrong Evidence
Increase
Antiulcer (acid-suppressive) drugs taken for several months
You can become newly sensitized to hazelnut while on long-term acid suppression. In 153 gastroenterology patients followed during a 3-month course of antiulcer drugs, 3.3 percent developed new hazelnut-specific IgE, and some went on to develop clinical hazelnut allergy with positive food challenges. This represents true new allergic biology, not a measurement artifact.
MedicationModerate Evidence

Frequently Asked Questions

References

19 studies
  1. Flinterman a, Akkerdaas J, Den Hartog Jager C, Rigby N, Fernández-rivas M, Hoekstra M, Bruijnzeel-koomen C, Knulst a, Van Ree R, Pasmans SThe Journal of Allergy and Clinical Immunology2008
  2. Datema M, Zuidmeer-jongejan L, Asero R, Barreales L, Belohlavkova S, De Blay F, Bures P, Clausen M, Dubakiene R, Gíslason D, Jędrzejczak-czechowicz M, Kowalski M, Knulst a, Kralimarkova T, Le T, Lovegrove a, Marsh J, Papadopoulos N, Popov T, Del Prado N, Purohit a, Reese G, Reig I, Seneviratne S, Sinaniotis a, Versteeg S, Vieths S, Zwinderman a, Mills C, Lidholm J, Hoffmann-sommergruber K, Fernández-rivas M, Ballmer-weber B, Van Ree RThe Journal of Allergy and Clinical Immunology2015
  3. Bellia C, Sardina DS, Scazzone C, Lio D, Scola L, Uasuf CGInternational Journal of Molecular Sciences2024
  4. Valcour a, Lidholm J, Borres M, Hamilton RThe Journal of Allergy and Clinical Immunology2019
  5. Valbuena T, Reche M, Marco G, Toboso I, Ringauf a, Thuissard-vasallo I, Lozano-ojalvo D, Martínez-blanco M, Molina EFoods2021